Benzinga - Tue, 20 Apr 2021 13:27:15 -0400
Benzinga - Thu, 15 Apr 2021 18:25:41 -0400
Benzinga - Thu, 15 Apr 2021 07:35:54 -0400
Benzinga - Wed, 14 Apr 2021 16:38:49 -0400
Benzinga - Tue, 30 Mar 2021 17:40:42 -0400
Benzinga - Wed, 24 Mar 2021 17:14:01 -0400
Benzinga - Fri, 19 Mar 2021 17:25:20 -0400
Benzinga - Thu, 18 Mar 2021 17:08:19 -0400
Benzinga - Wed, 17 Mar 2021 18:03:56 -0400
Benzinga - Wed, 17 Mar 2021 05:12:26 -0400
Benzinga - Tue, 16 Mar 2021 17:19:50 -0400
Benzinga - Tue, 16 Mar 2021 12:40:54 -0400
Benzinga - Tue, 16 Mar 2021 12:06:53 -0400
Benzinga - Tue, 16 Mar 2021 08:29:53 -0400
Benzinga - Tue, 16 Mar 2021 07:44:06 -0400
load more
Sector: Health Care.Industry: Pharmaceuticals
Zynerba Pharmaceuticals Inc is a pharmaceutical company that is focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product pipeline consists Zygel which is a pharmaceutically-produced CBD, a non-euphoric cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-10
REV
Q4 2020Est.ActualSurprise
EPS-0.320-0.330 -0.0100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ZYNEZynerba Pharmaceuticals1.83%160.9M

Zynerba Pharmaceuticals Company Questions & Answers

Q

How do I buy Zynerba Pharmaceuticals (ZYNE) stock?

A

You can purchase shares of Zynerba Pharmaceuticals (NASDAQ: ZYNE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Zynerba Pharmaceuticals's (ZYNE) main competitors?

A

Other companies in Zynerba Pharmaceuticals’s space includes: Onconova Therapeutics (NASDAQ:ONTX), Xeris Pharmaceuticals (NASDAQ:XERS) and Satsuma Pharmaceuticals (NASDAQ:STSA).

Q

What is the target price for Zynerba Pharmaceuticals?

A

The latest price target for Zynerba Pharmaceuticals (NASDAQ: ZYNE) was reported by Needham on 2020-07-01. The analyst firm set a price target for 0.00 expecting ZYNE to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.

Q

How much is Zynerba Pharmaceuticals (ZYNE) stock ?

A

The stock price for Zynerba Pharmaceuticals (NASDAQ: ZYNE) is $3.9 last updated Today at 4:20:32 PM.

Q

When is the next Zynerba Pharmaceuticals (ZYNE) dividend?

A

There are no upcoming dividends for Zynerba Pharmaceuticals.

Q

When is Zynerba Pharmaceuticals (NASDAQ:ZYNE) reporting earnings?

A
Zynerba Pharmaceuticals’s Q1 earnings are confirmed from now on May 10, 2021.
Q

When is the upcoming split for ZYNE?

A

There is no upcoming split for Zynerba Pharmaceuticals.